Tscan Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +0.7% | +278.2% | +5.8% | +36.7% | +36.4% | -38.4% | |
| – | -14.0% | +354.5% | -25.1% | +56.5% | +50.7% | -46.3% | |
| – | -16.7% | +363.9% | -25.6% | +11.1% | +34.0% | -14.7% | |
| – | -16.7% | +363.9% | -25.6% | +60.0% | +51.1% | -47.5% | |
| – | +95.5% | -6.1% | -14.2% | – | – | – | |
| – | +1,248.0% | -70.4% | +264.7% | +21.7% | +7.3% | -18.8% | |
| – | +628.1% | +22.3% | -18.9% | +72.3% | +20.6% | -48.0% | |
| – | +219.4% | +16.7% | +123.0% | +79.1% | -30.7% | +56.8% | |
| – | +188.1% | -39.3% | +65.0% | -18.5% | +80.2% | -71.0% | |
| – | – | – | – | -8.8% | +20.1% | +1.4% | |
| – | -199.8% | – | -38.2% | +51.7% | +59.7% | -48.9% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | -4.1% | +0.6% | +172.8% | +70.7% | +16.0% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.